Connecticut Innovations Increases Early-Stage Investments to $9.4 Million in Q3 of 2021 Fiscal Year
- Connecticut Innovations announces $9.4 million in investments in early-stage Connecticut companies for the third quarter of its fiscal year
- Investments are concentrated in bioscience, health care information technology, and IT companies
- Funding helps leverage $124 million in outside capital